Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease
- 28 February 2013
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 97 (2), 161-168
- https://doi.org/10.1016/j.antiviral.2012.11.005
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and CoronavirusesJournal of Virology, 2012
- Spike Protein Fusion Peptide and Feline Coronavirus VirulenceEmerging Infectious Diseases, 2012
- Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assayVirology, 2012
- Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C proteaseBioorganic & Medicinal Chemistry Letters, 2011
- AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In VivoPLOS ONE, 2011
- Pathogenic characteristics of persistent feline enteric coronavirus infection in catsVeterinary Research, 2010
- Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronavirusesVeterinary Microbiology, 2008
- Treatment of cats with feline infectious peritonitisVeterinary Immunology and Immunopathology, 2008
- Endosomal Proteolysis by Cathepsins Is Necessary for Murine Coronavirus Mouse Hepatitis Virus Type 2 Spike-Mediated EntryJournal of Virology, 2006
- Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main ProteasesPLoS Biology, 2005